Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05963594 · ClinicalTrials.gov registry record · NA
To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT05963594 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 44 participants.
The verdict
NCT05963594, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The goal of this mechanistic, exploratory study is to compare the effectiveness of Oligomalt to Glucidex 40 after eating in adults with Type 2 Diabetes (T2D) and in otherwise healthy adults with overweight or obesity (HAO).
Interventions
- DIETARY_SUPPLEMENT maltodextrin
- DIETARY_SUPPLEMENT Oligomalt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-01-23 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05963594
The ClinicalTrials.gov registry entry for NCT05963594 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which maltodextrin is the first listed.
NCT05963594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05963594 about?
NCT05963594 is a clinical study titled "To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO". The goal of this mechanistic, exploratory study is to compare the effectiveness of Oligomalt to Glucidex 40 after eating in adults with Type 2 Diabetes (T2D) and in otherwise healthy adults with overweight or obesity (HAO).
What is the current status of trial NCT05963594?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2023-01-23. Estimated completion is 2023-03-28.
What interventions are being tested in trial NCT05963594?
The interventions under investigation include: maltodextrin (DIETARY_SUPPLEMENT), Oligomalt (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05963594?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.